financetom
Business
financetom
/
Business
/
What's Going On With Sidus Space Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Sidus Space Stock Today?
Oct 17, 2024 12:53 PM

Sidus Space, Inc. ( SIDU ) shares are trading lower on Tuesday.

In an SEC filing, the company announced an offering of 3.75 million shares at an assumed price of $2.67 per share. The offering also contains up to 3.745 million pre-funded warrants to purchase up to 3.745 million shares of Class A common stock.

Per Sidus Space ( SIDU ), the net proceeds from this offering will be approximately $8.9 million. The firm will use the net proceeds from this offering for sales and marketing, operational costs, product development, manufacturing expansion, and working capital, along with other general corporate purposes.

Also Read: Oil Prices Take Largest Plunge In Over A Year As Israel Vows To Spare Iranian Facilities: Energy Stocks Sink, Airlines, Cruise Lines Rally

In a press release, Sidus Space ( SIDU ) announced that the U.S. Federal Communications Commission (FCC) has approved its operation of a micro constellation of remote sensing, multi-mission satellites in Low Earth Orbit (LEO).

This regulatory milestone is a significant step in Sidus Space’s plans for on-orbit expansion and underscores its strategic commitment to enabling new missions while delivering flexible, cost-effective data acquisition solutions through its innovative data-as-a-service model.

The company retains ownership of the data collected by its LizzieSat sensors for all missions, giving customers a distinct advantage in accessing valuable data streams.

The FCC approval marks a significant milestone for Sidus Space ( SIDU ) as it expands its on-orbit presence and enhances its capacity to provide a variety of industries with improved real-time, space-based data services.

According to Benzinga Pro, SIDU stock has lost over 79% in the past year.

Price Action: SIDU shares are trading lower by 11.2% to $2.335 at last check Tuesday.

Read Next:

State Street Q3 Earnings: AUM Soars To $4.7T, Announces CFO Eric Aboaf’s Departure In 2025

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved